+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cholesterol Testing: Global Strategic Business Report

  • PDF Icon

    Report

  • 273 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 338881

Global Cholesterol Testing Market to Reach $31.7 Billion by 2030

The global market for Cholesterol Testing estimated at US$22 Billion in the year 2022, is projected to reach a revised size of US$31.7 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2022-2030. Diagnostic Centers, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$11.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Physicians / Providers & Hospitals segment is readjusted to a revised 4.6% CAGR for the next 8-year period.

The U.S. Market is Estimated at $6.4 Billion, While China is Forecast to Grow at 8% CAGR

The Cholesterol Testing market in the U.S. is estimated at US$6.4 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$5.9 Billion by the year 2030 trailing a CAGR of 8% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.6% and 5.3% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.4 Billion by the year 2030.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • AccuTech LLC
  • Akers Biosciences Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Home Access Health Corporation
  • Laboratory Corporation of America® Holdings
  • PTS Diagnostics
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corp.

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and Research Platform
  • Complimentary updates for one year

Frequently Asked Questions about the Global Market for Cholesterol Testing

What is the estimated value of the Global Market for Cholesterol Testing?

The Global Market for Cholesterol Testing was estimated to be valued at $22 Billion in 2022.

What is the growth rate of the Global Market for Cholesterol Testing?

The growth rate of the Global Market for Cholesterol Testing is 4.7%, with an estimated value of $31.7 Billion by 2030.

What is the forecasted size of the Global Market for Cholesterol Testing?

The Global Market for Cholesterol Testing is estimated to be worth $31.7 Billion by 2030.

Who are the key companies in the Global Market for Cholesterol Testing?

Key companies in the Global Market for Cholesterol Testing include Abbott Laboratories, AccuTech LLC, Akers Biosciences Inc., Beckman Coulter Inc., Bio, Rad Laboratories Inc., Boston Heart Diagnostics Corporation, Eurofins Scientific, F. Hoffmann and La Roche Ltd..

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Cholesterol Testing - An Overview
  • Recent Market Activity
  • Prevailing Scenario in the Global Healthcare Sector Favors Market Growth
  • Increasing Healthcare Expenditure
  • Wider Availability of Healthcare & Diagnostics Services
  • Growing Health-Consciousness
  • Lenience Towards Preventive Care
  • Cholesterol Testing - Global Key Competitors Percentage Market Share in 2022 (E)
  • Developed Regions Remain Key Revenue Contributors
  • Developing Economies Offer Significant Potential
  • Key Factors Driving Demand for Healthcare Services in Developing Regions
  • Impact of Covid-19 and a Looming Global Recession
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
  • Abbott Laboratories (USA)
  • AccuTech, LLC (USA)
  • Akers Biosciences, Inc. (USA)
  • Beckman Coulter, Inc. (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Eurofins Scientific (Luxembourg)
  • Boston Heart Diagnostics Corporation (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Home Access Health Corporation (USA)
  • Laboratory Corporation of America® Holdings (USA)
  • PRIMA Lab SA (Switzerland)
  • PTS Diagnostics (USA)
  • Quest Diagnostics, Inc. (USA)
  • Randox Laboratories Ltd. (UK)
  • Sekisui Diagnostics, LLC (USA)
  • Siemens Healthineers (Germany)
  • Sigma-Aldrich Corp. (USA)
3. MARKET TRENDS & DRIVERS
  • Growing Prevalence of Cardiovascular Disease Steers Cholesterol Testing Volumes
  • Global Menace of Cardiovascular Disease: Quick Facts
  • A Brief Overview of Select Cholesterol-Driven Cardiac Disorders
  • Coronary Artery Disease
  • Hyperlipidaemia
  • CVD Statistics
  • Risk of CVD in Obese People Underpins Cholesterol Testing Volumes
  • Global Obesity Facts in a Nutshell
  • Cholesterol Screening Assumes Importance in Diabetes Care
  • Global Diabetes Expenditure: Opportunity Indicator
  • The Hypertension-Cholesterol Link Accelerates the Need for Cholesterol Screening
  • Aging Population - A Vital Demography
  • Uptrend in In-Vitro Diagnostics (IVD) Sector Signals Prospects
  • Healthy Growth in Cardiac IVD Market Augments Market Potential
  • Positive Momentum in Point of Care (POC) Diagnostics Generates Parallel Opportunities
  • POC Diagnostics - An Overview
  • POC Cholesterol Testing Makes Rapid Gains
  • Massive Demand for Lipid Panel/Lipid Profile Tests
  • Northbound Trajectory in POC LPT Services
  • Rise of C-reactive Protein Tests to Aid Market Growth
  • Cholesterol Testing: Evolution from Invasive to Non-Invasive
  • Recent Breakthroughs in Non-Invasive Cholesterol Testing Domain
  • Nonfasting Lipid Testing Invalidates the Need for Pre-Test Fasting
  • Cloud Screening Platforms Extend New Level of Convenience
  • Self-Testing Kits: An Emerging Issue for Full-Scale Services Providers
  • A Rapidly Evolving Market Enabled by Technology
  • Opportunities & Challenges in Self-Testing Industry
  • E-Retailing Drives Sales of Home Test Kits
  • A Brief Overview of Select Cholesterol Test Kits
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World Historic Review for Cholesterol Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 3: World 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2012, 2023 & 2030
  • Table 4: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 5: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 6: World 18-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World Historic Review for Physicians / Providers & Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 9: World 18-Year Perspective for Physicians / Providers & Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 10: World Recent Past, Current & Future Analysis for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 11: World Historic Review for Government Agencies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 12: World 18-Year Perspective for Government Agencies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2012, 2023 & 2030
  • Table 13: World Cholesterol Testing Market Analysis of Annual Sales in US$ Million for Years 2012 through 2030
III. MARKET ANALYSIS
UNITED STATES
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 14: USA Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 15: USA Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 16: USA 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
CANADA
  • Table 17: Canada Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 18: Canada Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 19: Canada 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
JAPAN
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 20: Japan Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 21: Japan Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 22: Japan 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
CHINA
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 23: China Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 24: China Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 25: China 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
EUROPE
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 26: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 27: Europe Historic Review for Cholesterol Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 28: Europe 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2012, 2023 & 2030
  • Table 29: Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 30: Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 31: Europe 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
FRANCE
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 32: France Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: France Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 34: France 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
GERMANY
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 35: Germany Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 36: Germany Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 37: Germany 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
ITALY
  • Table 38: Italy Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: Italy Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 40: Italy 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
UNITED KINGDOM
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 41: UK Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 42: UK Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 43: UK 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
SPAIN
  • Table 44: Spain Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Spain Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 46: Spain 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
RUSSIA
  • Table 47: Russia Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 48: Russia Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 49: Russia 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
REST OF EUROPE
  • Table 50: Rest of Europe Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: Rest of Europe Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 52: Rest of Europe 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
ASIA-PACIFIC
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 53: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 54: Asia-Pacific Historic Review for Cholesterol Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 55: Asia-Pacific 18-Year Perspective for Cholesterol Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2012, 2023 & 2030
  • Table 56: Asia-Pacific Recent Past, Current & Future Analysis for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Asia-Pacific Historic Review for Cholesterol Testing by End-Use - Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies Markets - Independent Analysis of Annual Sales in US$ Million for Years 2012 through 2021 and % CAGR
  • Table 58: Asia-Pacific 18-Year Perspective for Cholesterol Testing by End-Use - Percentage Breakdown of Value Sales for Diagnostic Centers, Physicians / Providers & Hospitals and Government Agencies for the Years 2012, 2023 & 2030
AUSTRALIA
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Cholesterol Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
IV. COMPETITION

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • AccuTech LLC
  • Akers Biosciences Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Boston Heart Diagnostics Corporation
  • Eurofins Scientific
  • F. Hoffmann-La Roche Ltd.
  • Home Access Health Corporation
  • Laboratory Corporation of America® Holdings
  • PTS Diagnostics
  • Quest Diagnostics Inc.
  • Randox Laboratories Ltd.
  • Sekisui Diagnostics LLC
  • Siemens Healthineers
  • Sigma-Aldrich Corp.